Phase 3 Fracture Trial Of Odanacatib For Osteoporosis - Baseline Characteristics and Study Design

Author(s):
Papapoulos, S.; Bone, H.G.; Dempster, D.W.; Eisman, J.; Greenspan, S.; McClung, M.; Nakamura, T.; Shih, J.; Leung, A.; Santora, A.; Verbruggen, N.; Lombardi, A.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S515-S516
hdl
1887/100419